382 related articles for article (PubMed ID: 31164474)
1. Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia.
Li L; Foo BJW; Kwok KW; Sakamoto N; Mukae H; Izumikawa K; Mandard S; Quenot JP; Lagrost L; Teh WK; Singh Kohli G; Zhu P; Choi H; Buist ML; Seet JE; Yang L; He F; Kwong Chow VT; Tan NS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164474
[TBL] [Abstract][Full Text] [Related]
2.
Bradshaw JL; Caballero AR; Bierdeman MA; Adams KV; Pipkins HR; Tang A; O'Callaghan RJ; McDaniel LS
mSphere; 2018; 3(3):. PubMed ID: 29720526
[TBL] [Abstract][Full Text] [Related]
3. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia.
Matarazzo L; Casilag F; Porte R; Wallet F; Cayet D; Faveeuw C; Carnoy C; Sirard JC
Front Immunol; 2019; 10():723. PubMed ID: 31024555
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.
Tavares LP; Garcia CC; Vago JP; Queiroz-Junior CM; Galvão I; David BA; Rachid MA; Silva PM; Russo RC; Teixeira MM; Sousa LP
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):24-34. PubMed ID: 26677751
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice.
Gotts JE; Chun L; Abbott J; Fang X; Takasaka N; Nishimura SL; Springer ML; Schick SF; Calfee CS; Matthay MA
Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L25-L40. PubMed ID: 29543040
[TBL] [Abstract][Full Text] [Related]
8. Immunization with pneumococcal polysaccharide serotype 3 and lipopolysaccharide modulates lung and liver inflammation during a virulent Streptococcus pneumoniae infection in mice.
Restori KH; Kennett MJ; Ross AC
Clin Vaccine Immunol; 2013 May; 20(5):639-50. PubMed ID: 23389932
[TBL] [Abstract][Full Text] [Related]
9. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
Aguilera ER; Lenz LL
Front Immunol; 2020; 11():105. PubMed ID: 32117259
[TBL] [Abstract][Full Text] [Related]
10. Increased Pulmonary Pneumococcal Clearance after Resolution of H9N2 Avian Influenza Virus Infection in Mice.
Li J; Wang H; Lian P; Bai Y; Zhang Z; Zhao L; Xu T; Qiao J
Infect Immun; 2021 May; 89(6):. PubMed ID: 33722928
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag
Felix KM; Jaimez IA; Nguyen TV; Ma H; Raslan WA; Klinger CN; Doyle KP; Wu HJ
Front Cell Infect Microbiol; 2018; 8():118. PubMed ID: 29755958
[No Abstract] [Full Text] [Related]
12. The Alpha-Tocopherol Form of Vitamin E Boosts Elastase Activity of Human PMNs and Their Ability to Kill
Bou Ghanem EN; Lee JN; Joma BH; Meydani SN; Leong JM; Panda A
Front Cell Infect Microbiol; 2017; 7():161. PubMed ID: 28516066
[TBL] [Abstract][Full Text] [Related]
13. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.
Yang Z; Chiou TT; Stossel TP; Kobzik L
Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
15. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
SMITH MR; WOOD WB
J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
[TBL] [Abstract][Full Text] [Related]
16. IL-6 During Influenza-
Gou X; Yuan J; Wang H; Wang X; Xiao J; Chen J; Liu S; Yin Y; Zhang X
Front Immunol; 2019; 10():3102. PubMed ID: 32038632
[TBL] [Abstract][Full Text] [Related]
17. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
[TBL] [Abstract][Full Text] [Related]
18. Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
van den Boogaard FE; van 't Veer C; Roelofs JJ; Meijers JC; Schultz MJ; Broze GJ; van der Poll T
Thromb Haemost; 2015 Jul; 114(1):115-22. PubMed ID: 25832548
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
Fukuda Y; Furuya Y; Nozaki Y; Takahata M; Nomura N; Mitsuyama J
Diagn Microbiol Infect Dis; 2014 Feb; 78(2):168-71. PubMed ID: 24321356
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection.
Amory-Rivier CF; Mohler J; Bédos JP; Azoulay-Dupuis E; Henin D; Muffat-Joly M; Carbon C; Moine P
Crit Care Med; 2000 Sep; 28(9):3249-56. PubMed ID: 11008989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
